Pre-eclampsia


Pre-eclampsia
HIV
Paranoia
SUNHA
The benefits are immediate and the potential for impact increases with every new patient onboarded.
Mental Health
Maternal Health
Infectious Diseases
Cardiovascular and Metabolics
designed to re-engage a whole patient population, whilst streamlining clinical workflows and delivered through our partnership with Chelsea and Westminster NHS Foundation Trust.
designed to treat paranoia that is following the strict regulatory path required to receive MHRA approval as an SaMD (software as a medical device) and be prescribed to patients.
Problem Pulmonary arterial hypertension (PAH) is a rare, progressive, and life-threatening condition, for which there is no cure and therefore requires constant management by patients. Avegen was given the task to set-up a digital health solution that will support patient self-management and improve the patient-clinician connect. The goal of PAH management is to maintain low-risk […]
STOP (Successful Treatment Of Paranoia) is a patient-facing app that aims to reduce clinical symptoms of paranoia, in patients with mild to moderate paranoia. It is a self-administered 12-week programme using Cognitive Bias Modification for Interpretation therapy (CBM-I). Avegen in collaboration with King’s College London designed and set up STOP, the smartphone version of the therapy.
Klick is a digitally-enabled HIV care pathway conceptualised by Chelsea and Westminster Hospital Foundation Trust (CWFT), Avegen and a major pharmaceutical company. Klick was designed and built by Avegen to integrate with and enhance CWFT’s outpatient service model, whilst delivering a positive experience for patients.
HealthMachine™ – Avegen’s proprietary product development platform, means you can scale your DHPs to millions of patients, wherever they are in the world and whatever their condition.
It supports the full spectrum of DHPs, including products seeking regulatory approval.
See how HealthMachine™ can deliver your strategic priorities.
Engagement Lead
Patient
Pregnant mother
Regional Digital Stakeholder Engagement Lead
Get in touch to see how you can use HealthMachine™ to deliver a transformative digital health product to your patients in under 3 months.
Problem Pulmonary arterial hypertension (PAH) is a rare, progressive, and life-threatening condition, for which there is no cure and therefore requires constant management by patients. Avegen was given the task to set-up a digital health solution that will support patient self-management and improve the patient-clinician connect. The goal of PAH management is to maintain low-risk […]
STOP (Successful Treatment Of Paranoia) is a patient-facing app that aims to reduce clinical symptoms of paranoia, in patients with mild to moderate paranoia. It is a self-administered 12-week programme using Cognitive Bias Modification for Interpretation therapy (CBM-I). Avegen in collaboration with King’s College London designed and set up STOP, the smartphone version of the therapy.
Klick is a digitally-enabled HIV care pathway conceptualised by Chelsea and Westminster Hospital Foundation Trust (CWFT), Avegen and a major pharmaceutical company. Klick was designed and built by Avegen to integrate with and enhance CWFT’s outpatient service model, whilst delivering a positive experience for patients.